(AGENPARL) – SILVER SPRING lun 10 aprile 2023 Remarks by Robert M. Califf, M.D. Commissioner of Food and Drugs 2023 Rx…
Browsing: FDA
(AGENPARL) – SILVER SPRING ven 07 aprile 2023 The U.S. Food and Drug Administration is providing an at-a-glance summary of news…
(AGENPARL) – SILVER SPRING ven 07 aprile 2023 Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C…
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products…
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 La FDA actualiza la información sobre los reportes de carcinoma de células escamosas…
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 Today, the FDA announced the final decision to withdraw approval of Makena—a drug…
(AGENPARL) – SILVER SPRING mer 05 aprile 2023 FDA OCI, Amy Winslow, Needham Heights, Mass, Hossein Maleknia, Bonita Springs, Fla, Reba…
(AGENPARL) – SILVER SPRING mer 05 aprile 2023 Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or…
(AGENPARL) – SILVER SPRING mar 04 aprile 2023 FDA authorizes Gohibic (vilobelimab) injection Fonte/Source: http://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-gohibic-vilobelimab-injection-treatment-covid-19
(AGENPARL) – SILVER SPRING mar 04 aprile 2023 The U.S. Food and Drug Administration is providing an at-a-glance summary of news…